Procter & Gamble Health Limited (BOM:500126)
India · Delayed Price · Currency is INR 6,781.40
+57.80 (0.86%)
At close: Jul 27, 2026
Procter & Gamble Health Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 24, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
| 112,567 | 79,646 | 85,359 | 83,824 | 87,133 | 69,507 | |
Market Cap Growth | 14.54% | -6.69% | 1.83% | -3.80% | 25.36% | -25.15% |
Enterprise Value | 110,807 | 76,847 | 82,715 | 79,677 | 83,155 | 67,334 |
Last Close Price | 6781.40 | 4798.15 | 4956.91 | 4739.33 | 4701.51 | 3704.68 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 24, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
PE Ratio | 34.43 | 24.36 | 33.98 | 41.71 | 37.97 | 36.10 |
PS Ratio | 7.99 | 5.66 | 7.01 | 7.28 | 7.09 | 6.24 |
PB Ratio | 21.46 | 15.18 | 15.90 | 15.57 | 11.60 | 11.28 |
P/TBV Ratio | 21.48 | 15.20 | 15.92 | 15.60 | 11.62 | 11.28 |
P/FCF Ratio | 34.93 | 24.71 | 39.98 | 40.58 | 45.03 | 52.82 |
P/OCF Ratio | 33.32 | 23.58 | 37.95 | 36.72 | 36.92 | 41.00 |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 24, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
EV/Sales Ratio | 7.87 | 5.46 | 6.79 | 6.92 | 6.76 | 6.04 |
EV/EBITDA Ratio | 24.26 | 16.83 | 22.84 | 26.26 | 26.09 | 25.43 |
EV/EBIT Ratio | 25.59 | 17.75 | 24.11 | 28.55 | 28.11 | 27.76 |
EV/FCF Ratio | 34.38 | 23.85 | 38.74 | 38.57 | 42.97 | 51.17 |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 24, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Debt / Equity Ratio | 0.02 | 0.02 | 0.01 | 0.02 | 0.02 | 0.01 |
Debt / EBITDA Ratio | 0.02 | 0.02 | 0.02 | 0.03 | 0.04 | 0.01 |
Debt / FCF Ratio | 0.03 | 0.03 | 0.04 | 0.05 | 0.06 | 0.02 |
Net Debt / Equity Ratio | -0.34 | -0.34 | -0.32 | -0.42 | -0.56 | -0.51 |
Net Debt / EBITDA Ratio | -0.38 | -0.38 | -0.48 | -0.75 | -1.33 | -1.20 |
Net Debt / FCF Ratio | -0.55 | -0.55 | -0.82 | -1.11 | -2.19 | -2.41 |
Asset Turnover | 1.72 | 1.72 | - | 1.22 | 1.24 | 1.19 |
Inventory Turnover | 2.97 | 2.97 | - | 2.81 | 3.07 | 3.02 |
Quick Ratio | 1.44 | 1.44 | 1.60 | 1.54 | 1.85 | 1.77 |
Current Ratio | 2.18 | 2.18 | 2.44 | 2.40 | 2.62 | 2.62 |
Return on Equity (ROE) | 61.59% | 61.59% | - | 31.18% | 33.56% | 29.17% |
Return on Assets (ROA) | 33.10% | 33.10% | - | 18.41% | 18.59% | 16.18% |
Return on Invested Capital (ROIC) | 91.44% | 88.52% | 76.71% | 64.42% | 68.84% | 67.36% |
Return on Capital Employed (ROCE) | 73.80% | 73.80% | 59.30% | 48.50% | 37.10% | 37.00% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 24, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Earnings Yield | 2.90% | 4.11% | 2.94% | 2.40% | 2.63% | 2.77% |
FCF Yield | 2.86% | 4.05% | 2.50% | 2.46% | 2.22% | 1.89% |
Dividend Yield | 2.29% | 3.23% | 3.36% | 2.32% | 2.02% | 1.42% |
Payout Ratio | 104.09% | 104.09% | 123.36% | 87.36% | 40.87% | 147.44% |
Buyback Yield / Dilution | -0.00% | -0.00% | 0.00% | - | - | - |
Total Shareholder Return | 2.30% | 3.23% | 3.36% | 2.32% | 2.02% | 1.42% |